Nerve-Sparing vs Non Nerve-Sparing Prostatectomy: Key Outcomes

Nerve-sparing radical prostatectomy preserves the bundles of nerves running alongside the prostate that control erections and contribute to urinary control, while non-nerve-sparing surgery deliberately removes or sacrifices those bundles to ensure the widest possible cancer-free margin. The choice between the two shapes a patient’s recovery of sexual function, continence timeline, and psychological well-being, yet multiple large studies show that when patients are properly selected, nerve sparing does not compromise cancer control. The real question for most men facing prostatectomy is not simply “which is better” but rather which approach makes sense given their tumor characteristics, baseline function, and priorities.

What the Neurovascular Bundles Actually Do

The neurovascular bundles (NVBs) travel along the posterolateral surface of the prostate and carry parasympathetic nerve fibers responsible for triggering the blood-vessel dilation that produces an erection. During radical prostatectomy, the surgeon dissects the prostate away from surrounding tissue, and the NVBs sit dangerously close to that dissection plane. Damage can be mechanical, from traction or cutting, or thermal, from cautery instruments used to control bleeding during lateral or apical dissection.¹ Because these same nerve pathways also send branches to the urethral sphincter, preserving them has implications for bladder control as well, though continence depends on several additional anatomical factors.²

A detailed understanding of pelvic anatomy is considered essential for choosing the optimal dissection plane and minimizing NVB injury.³ In nerve-sparing surgery, the surgeon peels the prostate away from the NVBs using techniques that avoid heat and excessive pulling. In non-nerve-sparing surgery, the bundles are deliberately removed on one or both sides, either because the tumor is too close to the nerve plane or because the cancer risk profile demands the widest possible margin.

Erectile Function After Surgery

Sexual function is the outcome where nerve sparing makes the most dramatic difference. In bilateral nerve-sparing procedures, where both NVBs are preserved, potency recovery rates are substantially higher than when only one side is spared. One study found that doubling the preserved nerve volume increased the odds of recovering potency by about 15 to 36 percent, depending on surgical technique, with bilateral patients reaching potency rates as high as 93 percent in the best-case scenario and unilateral patients reaching around 80 percent when a clip-based, cautery-free technique was used.⁴ By 24 months, however, erectile function scores between unilateral and bilateral groups had converged, suggesting that given enough time, the remaining nerve tissue can adapt.

Even men who undergo non-nerve-sparing surgery are not universally condemned to permanent erectile dysfunction. A study of men who had nerves resected on one side (unilateral nerve resection) found that about a third recovered erectile function, while roughly 13 percent of men with bilateral nerve resection also recovered. Baseline erectile function before surgery and age were the strongest predictors of whether recovery occurred.⁵ That finding is often surprising to patients who have been told that losing both bundles means no chance of natural erections.

The timeline matters. A study comparing bilateral nerve sparing, unilateral nerve sparing, and non-nerve-sparing robot-assisted prostatectomy found that the bilateral group scored significantly higher on erectile function questionnaires at two and three months after surgery, but by six and twelve months the differences between all three groups were no longer statistically significant.⁶ Early recovery is faster with bilateral sparing, but longer-term outcomes are more closely tied to a man’s age, preoperative function, and comorbidities than to the number of bundles preserved.

Predicting Who Will Recover

Surgeons increasingly use prediction models to counsel patients before surgery. Key factors that consistently show up across studies include age, preoperative erection quality (typically measured with the IIEF questionnaire), overall health burden, and the extent of fascia preserved during the operation. One model showed that greater preservation of the anterior fascia around the NVB correlated with better postoperative erectile function, and that older men derived at least as much relative benefit from more extensive preservation as younger men, even though their starting scores were lower.⁷ Baseline sexual function and pretreatment PSA level also shape expectations, reinforcing the idea that a man who already has weakened erections before surgery will have a harder road back regardless of technique.⁸

Urinary Continence Recovery

Continence is the other major functional outcome, and nerve sparing appears to help here too, though the effect is smaller and the mechanisms are less straightforward. In a study of patients with preoperative erectile dysfunction (a group where nerve-sparing decisions are sometimes treated as less important), continence recovery rates at three months were about 55 percent in the nerve-sparing group versus 34 percent in the non-nerve-sparing group. By twelve months those numbers were roughly 85 percent and 78 percent, respectively. For patients older than 70, the benefit of nerve sparing was especially pronounced: continence reached 95 percent in the nerve-sparing group versus 69 percent in the non-nerve-sparing group.⁹

The bilateral-versus-unilateral question also applies to continence. A meta-analysis found that bilateral nerve sparing improved continence rates over unilateral at every time point measured, though the advantage shrank over time: the relative benefit was about 36 percent at six weeks but only 7 percent at two years or beyond.¹⁰ In practical terms, bilateral sparing gets men back into pads faster, but most unilateral patients catch up given enough time.

The plane of dissection also plays a role. Intrafascial nerve sparing, which stays closer to the prostate capsule and preserves more tissue around the NVB, showed significantly better continence at one, three, and six months compared to the standard interfascial technique. By twelve months, however, the advantage disappeared.¹¹ The pattern across all these comparisons is consistent: nerve sparing accelerates continence recovery, with the biggest payoff in the first few months.

Does Nerve Sparing Compromise Cancer Control?

This is the fear that kept many surgeons cautious about nerve sparing for years, and the evidence now provides substantial reassurance. One analysis found positive surgical margin rates of about 14 percent in the nerve-sparing group versus 18 percent in the non-nerve-sparing group, a difference that was not statistically significant.¹² Another large study using the SEARCH database found that neither bilateral nor unilateral nerve sparing increased the risk of biochemical recurrence when used on appropriately selected patients.¹³

A study specifically looking at recurrence within five years found that nerve-sparing patients actually had lower cumulative recurrence rates (about 14 percent) than non-nerve-sparing patients (about 21 percent), though this likely reflected selection bias: nerve-sparing patients tend to have more favorable disease. After adjusting for confounders, the hazard ratio was essentially 1.0, meaning no difference in recurrence risk.¹⁴

The question gets more nuanced with higher-risk tumors. For men with organ-confined disease (pT2), one study found a modest trend toward higher positive margin rates with bilateral nerve sparing, though it did not reach clear statistical significance. For locally advanced disease (pT3), there was no increase at all.¹⁵ And in a propensity-matched, long-term study of high-risk prostate cancer patients, nerve sparing showed no evidence of worse recurrence, cancer-specific survival, or overall survival compared to non-nerve-sparing surgery.¹⁶ A separate study of robot-assisted prostatectomy in high-risk cases found nearly identical biochemical recurrence-free survival at one and three years between the two approaches.¹⁷

How Surgeons Decide Whether to Spare the Nerves

The decision is not binary. A surgeon can spare nerves bilaterally, unilaterally, or not at all, and the choice is made based on where the tumor sits relative to the NVBs. Preoperative multiparametric MRI has become a critical tool in this planning. In one study, MRI findings changed the initial surgical plan in about a quarter of cases, with most of those changes being appropriate when checked against final pathology.¹⁸

MRI’s ability to detect extraprostatic extension, where tumor has grown beyond the prostate capsule, is particularly relevant because that is the scenario where cutting close to the nerves risks leaving cancer behind. The predictive value of MRI varies by risk group. Research has shown that MRI correlates strongly with extraprostatic extension in intermediate and high-risk cancers but performs less reliably in low-risk cases, where the tumor is less likely to have spread beyond the gland in the first place.¹⁹

NeuroSAFE and Intraoperative Margin Checks

One of the more promising innovations in bridging the gap between nerve sparing and cancer safety is the NeuroSAFE technique, short for neurovascular structure-adjacent frozen-section examination. The concept is straightforward: during the operation, the surgeon shaves a thin strip of tissue from the margin closest to the nerve bundle and sends it for rapid frozen-section analysis while the patient is still under anesthesia. If the pathologist finds cancer cells at the margin, the surgeon can go back and remove the NVB on that side before closing.²⁰

Studies suggest NeuroSAFE increases the rate of bilateral nerve preservation while simultaneously lowering positive margin rates. One comparison found that NeuroSAFE cases achieved bilateral sparing in about 81 percent of patients compared to 66 percent without it, while positive margins at the region of interest dropped from roughly 23 percent to about 3 percent.²¹ The technique’s biggest advantage may be in giving surgeons the confidence to attempt nerve sparing in higher-risk cases where they otherwise would have played it safe and resected the bundles.

The tradeoff is cost and operating time. From an NHS perspective, NeuroSAFE-guided surgery cost about £827 more per patient and produced a small gain in quality-adjusted life years, putting it near the borderline of commonly used cost-effectiveness thresholds.²² Whether it is worth the extra expense depends on how much a healthcare system values the functional gains, but the trend across Europe has been toward wider adoption.

Robotic Surgery and Nerve Sparing

Robot-assisted radical prostatectomy has become the dominant surgical approach in many countries, and the robotic platform appears to favor nerve preservation. A meta-analysis of prospective studies found that robotic surgery had a significantly higher nerve-sparing rate than open surgery, along with less blood loss, shorter hospital stays, and fewer overall complications. Robotic cases also showed benefits for postoperative erectile function recovery and biochemical recurrence rates, though continence recovery and positive margin rates were similar between the two approaches.²³ A separate meta-analysis confirmed improved urinary continence recovery at three months and better erectile function recovery with robotic surgery.²⁴

The magnification and instrument articulation of the robotic console allow finer dissection along the nerve plane, which likely explains why more bundles are preserved. This does not mean open surgery cannot achieve excellent nerve-sparing results in experienced hands, but the technological advantage is measurable across large study populations.

Penile Rehabilitation After Surgery

Regardless of whether nerves are spared, most men experience a period of erectile dysfunction after prostatectomy while damaged nerves recover. The concept of “penile rehabilitation” aims to maintain blood flow and tissue health in the penis during this window, typically using PDE5 inhibitors (the same class of drugs as sildenafil and tadalafil), vacuum devices, or injection therapy. A meta-analysis found that PDE5 inhibitors after nerve-sparing surgery produced significant improvements in erectile function scores and roughly doubled the odds of successful intercourse compared to placebo.²⁵

The question of whether these medications should be taken nightly or only as needed has been debated. A randomized trial comparing nightly sildenafil to on-demand use after minimally invasive nerve-sparing prostatectomy found no difference in erectile recovery at one year, suggesting that a scheduled nightly regimen is not necessary for most men.²⁶ Despite the theoretical appeal of keeping the tissue oxygenated around the clock, the clinical evidence has not shown a clear long-term advantage for nightly dosing over taking the medication when intercourse is anticipated.

More broadly, the evidence for penile rehabilitation as a formal protocol remains somewhat underwhelming. While laboratory studies support the rationale for early intervention, solid prospective randomized trials demonstrating clear long-term benefits of any specific rehabilitation strategy are still lacking.²⁷ Many clinicians still recommend it on a “can’t hurt, might help” basis, particularly for men who had good preoperative function and bilateral nerve sparing.

Long-Term Quality of Life

A large study in the New England Journal of Medicine established that nerve-sparing procedures mitigated the adverse effects of prostatectomy on sexual function when compared to non-nerve-sparing surgery.²⁸ But the picture changes over longer time horizons. A multiregional study comparing health-related quality of life in men five to ten years after surgery found that nerve-sparing and non-nerve-sparing survivors reported similar symptom burden, similar function scores, and comparable overall quality of life. The only significant difference was in sexual activity, where nerve-sparing patients reported higher levels.²⁹

That convergence on most quality-of-life measures is worth sitting with. It suggests that while nerve sparing genuinely matters for sexual recovery, the broader experience of living after prostatectomy, including urinary symptoms, energy levels, emotional health, and social function, evens out over time regardless of nerve status. The exception is sex, where the difference persists years later.

The Psychological Dimension

Qualitative research with men who underwent non-nerve-sparing prostatectomy reveals a more complex story than questionnaire scores can capture. Patients described sexual changes as a central challenge in their adaptive response, reporting difficulties not only with erections but with intimate relationships and overall psychosocial well-being. Many described a process of redefining what sexuality and intimacy meant to them after surgery, questioning earlier assumptions about sexual behavior and gradually adapting to a broader concept of closeness that did not depend on penetrative sex.³⁰ For men whose nerves could not be spared, this kind of psychological support and couples counseling may be as important as any medication regimen.

Emerging Technologies for Nerve Identification

One persistent challenge with nerve-sparing surgery is that the NVBs are difficult to see with the naked eye, even under robotic magnification. The nerves are embedded in fatty tissue, and their exact position varies between patients. Researchers are exploring intraoperative imaging tools to improve visualization. One approach uses indocyanine green (ICG), a dye injected intravenously that fluoresces under near-infrared light, to highlight the blood vessels running alongside the nerve bundles. Early clinical experience suggests that ICG angiography is simple, non-invasive, and helps surgeons identify key anatomical landmarks during dissection.³¹

Targeted fluorescent probes that bind directly to nerve tissue are also in development. One near-infrared probe tested in animal models was able to illuminate the NVBs around the prostate in real time, offering a potential path toward intraoperative nerve mapping that does not rely on indirect vascular landmarks.³² These technologies remain investigational, but they represent a possible future where the uncertainty about nerve location during surgery is dramatically reduced, making nerve-sparing decisions more precise and less dependent on the surgeon’s experience and anatomical intuition.